Connective tissue growth factor fragments and methods and uses thereof
CA 2354422 A1 · Owner: University Of Miami · Inventors: Grotendorst, Gary R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed to CTGF fragments comprising at least exon 2 or exon 3 of CTGF and having the ability to induce extracellular matrix synthesis, in particular collagen synthesis and , myofibroblast differentiation. The present invention is further directed to methods using said CTGF fragments to identify compositions which modulate the activity of acid CTGF fragments and to the compositions so identified. The invention also relates to methods of treating CTGFassociated disorders and diseases associated with the overproduction of the extracellular matrix.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 14, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 14, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 14, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.